TABLE 4.
HDIμ |
HDIδ |
% of δ |
|||||||||
Groups | μ | σ | LL | UL | δ | LL | UL | % of δ > 0 | < ROPE | in ROPE | > ROPE |
GAD | 1.58 | 2.98 | 1.10 | 2.06 | 0.53 | 0.37 | 0.72 | 100 | 0 | 0 | 100 |
PA | 1.49 | 2.68 | 0.96 | 2.01 | 0.55 | 0.35 | 0.77 | 100 | 0 | 0.02 | 99.99 |
IA | 1.24 | 2.69 | 0.54 | 1.96 | 0.46 | 0.19 | 0.75 | 99.90 | 0 | 3.19 | 96.81 |
SAD | 1.03 | 2.73 | 0.45 | 1.54 | 0.38 | 0.17 | 0.57 | 99.98 | 0 | 4.96 | 95.05 |
DP | 1.55 | 3.10 | 1.27 | 1.81 | 0.50 | 0.41 | 0.59 | 100 | 0 | 0 | 100 |
OCD | 0.92 | 2.79 | 0.16 | 1.56 | 0.33 | 0.06 | 0.57 | 98.64 | 0 | 17.21 | 82.74 |
BDD | 1.64 | 2.62 | 0.88 | 2.60 | 0.63 | 0.30 | 1.06 | 100 | 0 | 0.30 | 99.71 |
ED | 1.38 | 2.75 | 0.80 | 1.97 | 0.50 | 0.28 | 0.74 | 100 | 0 | 0.33 | 99.68 |
SP | 1.35 | 2.62 | 0.45 | 2.30 | 0.52 | 0.14 | 0.94 | 99.52 | 0 | 3.77 | 96.18 |
Other | 0.83 | 2.43 | 0.41 | 1.24 | 0.34 | 0.17 | 0.52 | 100 | 0 | 5.55 | 94.46 |
HC | 1.56 | 2.66 | 1.37 | 1.73 | 0.58 | 0.51 | 0.65 | 100 | 0 | 0 | 100 |
Contrast MD vs. HC | −0.25 | −0.55 | 0.02 | −0.09 | −0.20 | 0.01 | 4.03 | 2.44 | 97.57 | 0 |
μ, median of posterior distribution of μ; σ, median of posterior distribution of σ; δ, median of posterior distribution of δ; HDIμ, 95% Highest Density Interval for μ with LL, lower limit and UL, upper limit; HDIδ, 95% Highest Density Interval for δ with LL, lower limit and UL, upper limit; % of δ > 0, percentage of the posterior distribution that is greater than the comparison value 0, i.e., no increase/decrease; % of δ < ROPE, percentage of the posterior distribution less than the lower limit; % of δ in ROPE, percentage of the posterior distribution in the interval; % of δ > ROPE, percentage of the posterior distribution higher than the upper limit. GAD, generalized anxiety disorder; PA, panic disorder and agoraphobia; IA, illness anxiety; SAD, social anxiety disorder; DP, depression; OCD, obsessive–compulsive disorder; BDD, body dysmorphic disorder ED, eating disorders; SP, schizophrenia spectrum and other psychotic disorders; other, other non-specified mental disorder; HC, healthy controls; Contrast MD vs. HC, contrast between all participants with a mental disorder (=MD; includes all groups with mental disorders from GAD to other) and healthy controls.